Citation Impact
Citing Papers
Chapter 4 Preparation of Isolated Rat Liver Cells
1976 Standout
Photodynamic Therapy
1998 Standout
Photodynamic therapy with endogenous protoporphyrin
1990 Standout
A review of etomidate for rapid sequence intubation in the emergency department
1997
Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council
2010 Standout
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Omega-3 fatty acids in health and disease and in growth and development
1991 Standout
Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload
1994
Hepatobiliary implications and complications in protoporphyria, a 20-year study
1989
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Porphyrias
2010 Standout
Photodynamic therapy for cancer
2003 Standout
Polychlorinated Biphenyls (PCBs), Dibenzo-p-Dioxins (PCDDs), Dibenzofurans (PCDFs), and Related Compounds: Environmental and Mechanistic Considerations Which Support the Development of Toxic Equivalency Factors (TEFs)
1990 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Airway Management in the Emergency Department: A One-Year Study of 610 Tracheal Intubations
1998 Standout
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
2013 Standout
A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria
1996
Photodynamic therapy: a new antimicrobial approach to infectious disease?
2004 Standout
Diagnosis and treatment of the hepatic porphyrias
2003
Erythropoietin for the Treatment of Porphyria Cutanea Tarda in a Patient on Long-Term Hemodialysis
1990
Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localization
2004 Standout
Enzyme induction in the cytochrome P-450 system
1990 Standout
Hypertension and renal disease in patients with acute intermittent porphyria
1994
Biochemical differentiation of the porphyrias
1999
5-Aminolevulinic acid-based photodynamic therapy
1997
Induction of δ-Aminolevulinic Acid Synthetase in Isolated Rat Liver Cell Suspensions
1974
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
ALUMINIUM POISONING: DIALYSIS ENCEPHALOPATHY, OSTEOMALACIA, AND ANAEMIA
1983
Management of porphyria cutanea tarda in the setting of chronic renal failure: A case report and review
2000
Left Ventricular Geometry and Severe Left Ventricular Hypertrophy in Children and Adolescents With Essential Hypertension
1998
Identification of a group of tetracarboxylate porphyrins, containing one acetate and three propionate β-substituents, in faeces from patients with symptomatic cutaneous hepatic porphyria and from rats with porphyria due to hexachlorobenzene
1972
Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Implications for the pathogenesis of porphyria
1983
Toxic effects of metals
1991 Standout
Total, LDL, and HDL Cholesterol Decrease With Age in Older Men and Women
1997
Cholesterol synthesis in vivo and in vitro in the WHHL rabbit, an animal with defective low density lipoprotein receptors
1983 StandoutNobel
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease
1971 Standout
Enzymatic Determination of Total Serum Cholesterol
1974 Standout
Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda
2000
Uroporphyrin accumulation produced by halogenated biphenyls in chick-embryo hepatocytes. Reversal of the accumulation by piperonyl butoxide
1986
Photodynamic Therapy in Dentistry
2007 Standout
The role of transferrin in the mechanism of cellular iron uptake
1990
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
Genetic, Metabolic, and Biochemical Aspects of the Porphyrias
1981
The estimation of cholesterol in serum:A classification and critical review of methods
1967
DEFICIENCY OF ESSENTIAL FATTY ACIDS AND ATHEROSCLEROSIS, ETCETERA
1956
Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias
1984
Induction of delta-aminolevulinate synthase and cytochrome P-450 hemoproteins in hepatocyte culture. Effect of glucose and hormones.
1981
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Current Metabolic-Genetic Interrelationship in Human Atherosclerosis
1968
Plasma Fluorescence Scanning and Fecal Porphyrin Analysis for the Diagnosis of Variegate Porphyria: Precise Determination of Sensitivity and Specificity with Detection of Protoporphyrinogen Oxidase Mutations as a Reference Standard
2004
Present Status of Research on Catabolism and Excretion of Cholesterol
1963
Works of L Eales being referenced
THE CLINICAL BIOCHEMISTRY OF THE HUMAN HEPATOCUTANEOUS PORPHYRIAS IN THE LIGHT OF RECENT STUDIES OF NEWLY IDENTIFIED INTERMEDIATES AND PORPHYRIN DERIVATIVES*
1975
Enzymatic defects in hepatic porphyria. Preliminary observations in patients with porphyria cutanea tarda and variegate porphyria.
1973
The effect of carbohydrate on δ-aminolaevulinate synthetase: The role of ribonucleic acid
1968
Coexistent Variegate Porphyria and Porphyria Cutanea Tarda
1982
The effect of bleeding and iron administration on the development of hexachlorobenzene-induced rat porphyria
1980
The Pattern of Porphyrin Isomer Accumulation and Excretion in Symptomatic Porphyria
1970
Disappearance of Human Growth Hormone125I in the Anephric Non-Uraemic and Uraemic Rat
1972
Clinical Aspects of Importance in the Porphyrias
1968
The diagnostic value of blood plasma porphyrin methyl ester profiles produced by quantitative TLC
1978
Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.
1979
Quantitative determination of cholesterol in serum with P-Toluene Sulphonic Acid
1957
Symptomatic Porphyria in a Case of Felty’s Syndrome. I. Clinical and Routine Biochemical Studies
1972
Symptomatic porphyria in a case of Felty's syndrome. II. Biochemical investigations.
1972
Liver involvement in erythropoietic protoporphyria (EP)
1980
SCREENING OF CERTAIN ANAESTHETIC AGENTS FOR THEIR ABILITY TO ELICIT ACUTE PORPHYRIC PHASES IN SUSCEPTIBLE PATIENTS
1980
Porphyrias and the Kidney
1981
Effect of Different Dietary Fats on the Fæcal End-Products of Cholesterol Metabolism
1957 Nature
Quantitation of red cell porphyrins by fluorescence scanning after thin-layer chromatography
1978
The hepatic lesion in protoporphyria (PP): preliminary studies of haem metabolism, liver structure and ultrastructure.
1976
II. Biochemical Investigations
1972
THE HISTOPATHOLOGY OF THE LIVER IN ACQUIRED (SYMPTOMATIC) PORPHYRIA.
1963
CORONARY-ARTERY DISEASE
1956
THE DIAGNOSTIC IMPORTANCE OF FAECAL PORPHYRINS IN THE DIFFERENTIATION OF THE PORPHYRIAS. II. VALUES IN THE CUTANEOUS PORPHYRIAS.
1963
Treatment of hemodialysis-related porphyria cutanea tarda with plasma exchange
1982
The metabolism of (5-14C)delta-aminolaevulic acid in normal and porphyric human subjects.
1968
The porphyrin peptides: practical implications.
1971